-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - not appropriately targeting the
remaining areas of uncertainty7 and emphasizes the need to clearly define
-
effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
January 01, 2018 - They may also help define
quality standards and provide insight into operational
considerations to
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cg/guidance-cg-cahps.pdf
April 01, 2021 - This information is used in the first question on the survey to define “this
provider” for the respondent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
August 01, 2012 - 1
Comparative Effectiveness Review
Number 63
First-Generation Versus Second-Generation
Antipsychotics in Adults:
Comparative Effectiveness
Executive Summary
Introduction
Antipsychotic medications are used
to treat and manage symptoms for
several psychiatric disorders and are
commonly categorized into tw…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer
Technical Brief Disposition of Comments Report
Research Review Title: Imaging Techniques for Treatment Evaluation for Metastatic Breast
Cancer
Draft review available for public comment from Februa…
-
effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
September 13, 2006 - Slide 1
Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals
Presented by
W. Douglas Evans, Ph.D.
Lauren McCormack, Ph.D., M.S.P.H
Presented at
Agency for Healthcare Research and Quality Conference:
Communicating Harms and Benefits of
…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
January 01, 2017 - Individualized Drug Interaction Alerts - Final Report
Individualized Drug Interaction Alerts
Investigators:
Daniel C. Malone, RPh, PhD, Principal Investigator
Richard D. Boyce, PhD, Co-Investigator
Philip Hansten, PharmD, Consultant
John R. Horn, PharmD, Consultant
Andrew Romero, PharmD, Consultan…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
July 29, 2014 - Technical Brief 16 Disposition of Comments Report
Technical Brief Disposition of Comments Report
Research Review Title: Decision Aids for Advance Care Planning
Draft review available for public comment from February 12, 2014 to March 11, 2014.
Research Review Citation: Butler M, Ratner E, McCreedy …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
December 21, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidy and Mortality: An Evidence Map
Comparative Effectiveness Review Disposition of Comments Report
Title: Social and Structural Determinants of Maternal Morbidity and Mortality: An
Evid…
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs018167-roberts-final-report-2013.pdf
January 01, 2013 - Self-Management & Reminders with Technology: SMART Appraisal of an Integrated PHR - Final Report
Title: Self-Management & Reminders with Technology: SMART Appraisal
of an Integrated PHR
Principal Investigator: Mark S. Roberts, MD, MPP
Team Members: Gary Fischer MD, University of Pittsburgh, Co-Investigator
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary
Comparative Effectiveness Review
Number 193
Effective Health Care Program
Management of Suspected Opioid Overdose
With Naloxone by Emergency Medical
Services Personnel
Executive Summary
Background…
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs014920-bellamy-final-report-2007.pdf
January 01, 2007 - Partnering to Improve Patient Safety in Rural WV - Final Report
Title of Project: Partnering to Improve Patient Safety in Rural
West Virginia Hospitals
Principal Investigator and Team Members
Gail R. Bellamy, Ph.D., Principal Investigator
…
-
psnet.ahrq.gov/perspective/emergence-trigger-tool-premier-measurement-strategy-patient-safety
May 01, 2012 - The Emergence of the Trigger Tool as the Premier Measurement Strategy for Patient Safety
Paul J. Sharek, MD, MPH | May 1, 2012
Also Read a Conversation
View more articles from the same authors.
Citation Text:
Sharek PJ. The Emergence of the Trigger Tool as the …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 13, 2012
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Amendment Date(s) if applicabl…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
October 01, 2019 - Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD
Purpose of Review
To evaluate the effectiveness and harms of pharmacologic and
nonpharmacologic treatments for exacerbations of chronic
obstructive pulmonary disease.
Key Messages
• Antibiotic therapy in…
-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - ORIGINAL ARTICLE
Heterogeneity and the Interpretation of Treatment Effect
Estimates From Risk Adjustment and Instrumental
Variable Methods
John M. Brooks, PhD,* and Elizabeth A. Chrischilles, PhD†
Objectives: To contrast the interpretations of treatment effect esti-
mates using risk adjustment and instrumental vari…
-
psnet.ahrq.gov/perspective/conversation-withdavid-c-classen-md-ms
May 01, 2012 - In Conversation With…David C. Classen, MD, MS
May 1, 2012
Also Read an Essay
Citation Text:
In Conversation With…David C. Classen, MD, MS. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 20…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-14-attach-1.pdf
January 01, 2011 - ADHD Performance Measurement Set
Attention Deficit Hyperactivity Disorder
Performance Measurement Set
Supported by AHRQ/CHIPRA-PQMP
Proposed by the ADHD Expert Work Group (listed in Appendix A)
In collaboration with the Pediatric Measurement Center of Excellence (PMCo…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-14-attachment-1.pdf
January 01, 2011 - Measure 1, Section 14, Attachment 1
Attention Deficit Hyperactivity Disorder
Performance Measurement Set
Supported by AHRQ/CHIPRA-PQMP
Proposed by the ADHD Expert Work Group (listed in Appendix A)
In collaboration with the Pediatric Measurement Center of Excellence (P…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfmethods.pdf
January 01, 2020 - Integrating Evidence-Based Clinical and Community Strategies to Improve Health
I
S
J
L
C
A
I
U
c
c
(
h
t
u
e
u
t
U
o
r
a
F
o
s
R
C
M
P
H
l
A
o
A
C
P
s
t
2
Review and Special Articles
ntegrating Evidence-Based Clinical and Community
trategies to Improve Health
udith K. Ockene, PhD, MEd, Elizabeth A. Edgerton…